Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CHAMPION-AF Clinical Trial

NCT: NCT04394546 · ACTIVE_NOT_RECRUITING

NCT IDNCT04394546
StatusACTIVE_NOT_RECRUITING
Start Date2020-10-15
Completion2027-12

Brief Summary

The primary objective of this study is to determine if left atrial appendage closure (LAAC) with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.

Frequently Asked Questions

What is CHAMPION-AF Clinical Trial?

CHAMPION-AF Clinical Trial is a clinical trial registered under NCT04394546. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04394546?

The current status of NCT04394546 (CHAMPION-AF Clinical Trial) is: ACTIVE_NOT_RECRUITING.

When did CHAMPION-AF Clinical Trial start?

CHAMPION-AF Clinical Trial started on 2020-10-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑